Effectiveness of lumacaftor/ivacaftor initiation in children with cystic fibrosis aged 2 through 5 years on disease progression: Interim results from an ongoing registry-based stud... von Kim, Claire, Higgins, Mark, Liu, Lingyun, Volkova, Nataliya, Zolin, Anna, Naehrlich, Lutz, Andreas, Pfleger (AT), Elise, Lammertijn (BE), Duška, Tješić-Drinković (HR), Pavel, Dřevínek (CZ), Milan, Macek, Hanne, Vebert Olesen (DK), Nathalie, Senecal (FR), Pierre-Régis, Burgel (FR), Godfrey, Fletcher (IE), Rita, Padoan (IT), Annalisa, Orenti (IT), Federico, Ambrogi (IT), Simone, Gambazza (IT), Elīna, Aleksejeva (LV), Anna-Maria, Charatsi (LU), Domenique, Zomer (NL), Egil, Bakkeheim (NO), Lukasz, Woźniacki (PL), Uroš, Krivec (SI), Christina, Krantz (SE), Anders, Lindblad (SE), Andreas, Jung (CH), Sarah, Clarke (UK), Siobhán B․, Carr (UK)

Volltext